Not checked for notices yet.

DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC

Hiroyuki Ogawa, Yasuhiro Sakai, Wataru Nishio and 8 more

Thoracic Cancer · 2020

doi:10.1111/1759-7714.13574

Cited by papers we hold 1

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer · 2023
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.